Acceptance of Telemedicine During the COVID-19 Pandemic
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to COVID-19
Related studies linked through entity extraction aliases.
Octagam 10% Therapy in COVID-19 Patients With Severe Disease Progression
- Status
- COMPLETED
- Phase
- PHASE3
Niclosamide for Mild to Moderate COVID-19
- Status
- COMPLETED
- Phase
- PHASE2
iNOPulse for COVID-19
- Status
- WITHDRAWN
- Phase
- PHASE2
Phase I/II Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) in Canada
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early
- Status
- COMPLETED
- Phase
- PHASE2
Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19
- Status
- COMPLETED
- Phase
- N/A
Mental Health Outcomes in Healthcare Workers During COVID-19
- Status
- COMPLETED
- Phase
- N/A
Psychological Impact of COVID-19 Quarantine and Worsening of Cardiovascular Risk in the French General Population
- Status
- COMPLETED
- Phase
- N/A
COVID-19 : Study of INFLAmmasome and PLAtelets Functions
- Status
- COMPLETED
- Phase
- N/A
COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2.
- Status
- COMPLETED
- Phase
- PHASE1
Hormonal Intervention for the Treatment in Veterans With COVID-19 Requiring Hospitalization
- Status
- COMPLETED
- Phase
- PHASE2
Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial)
- Status
- TERMINATED
- Phase
- NA
Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients
- Status
- COMPLETED
- Phase
- NA
A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of COVID-19 Convalescent Plasma
- Status
- COMPLETED
- Phase
- NA
Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury
- Status
- TERMINATED
- Phase
- PHASE4
Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19)
- Status
- UNKNOWN
- Phase
- PHASE2
COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada
- Status
- WITHDRAWN
- Phase
- PHASE3
Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe
- Status
- UNKNOWN
- Phase
- N/A